ARTICLE
Volume 4,Issue 2
31 December 2025
The Clinical Effect of Xuesaitong in the Treatment of Coronary Heart Disease and its Influence on the Hemorheology of Patients
Dejia Hu ,
Jihai Fan ,
Wei Gui ,
Zhen Li ,
Peng Zhao ,
Xianlei Deng ,
Chenran Guo ,
Lingui Xu
Show Less
1
Department of Cardiovascular Medicine, BOE Suzhou Hospital, Suzhou 215000, Jiangsu, China,
CR 2025 , 3(4), 29–34;
https://doi.org/10.26689/cr.v3i4.13333
© 2025 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
Objective: To explore the therapeutic effect of Xuesaitong on patients with coronary heart disease and its influence on their hemorheology. Methods: A total of 80 patients with coronary heart disease were included as observation samples. All of them received treatment in our hospital from January 2024 to January 2025. They were divided into the control group (n = 40, conventional treatment) and the observation group (n = 40, conventional treatment + Xuesaitong treatment) by lottery. The clinical efficacy was analyzed. Result: The therapeutic effect and the improvement of hemorheology in the observation group were both better than those in the control group, and the comparisons were statistically significant (P < 0.05). Conclusion: The treatment effect of Xuesaitong on patients with coronary heart disease is remarkable, and it is worthy of clinical promotion and application.
References
Wu J, Fu P, Wang Y, 2025, Clinical Study on Xuesaitong Soft Capsules Combined with Aspirin in the Treatment of Coronary Heart Disease in the Elderly. Modern Medicine and Clinical Practice, 40(7): 1711–1715.
Zhang R, 2023, Observation on the Therapeutic Effect of Xuesaitong Combined with Atorvastatin in the Treatment of Unstable Angina Pectoris of Coronary Heart Disease. Smart Health, 9(14): 251–254.
Dong Z, Han S, Lin L, et al. Comprehensive Evaluation Study of Xuesaitong Soft Capsules. Chinese Journal of Clinical Pharmacology, 37(12): 1612–1624.
Li X, Li H, Han L, et al., 2023, Research Progress on the Clinical Efficacy and Safety of Xuesaitong Injection. China Prescription Drugs, 21(11): 178–182.
Xu C, 2023, Therapeutic Effects of Xuesaitong Injection and Compound Danshen Drop Pills on Angina Pectoris of Coronary Heart Disease. Electronic Journal of Cardiovascular Diseases in Integrated Traditional Chinese and Western Medicine, 11(27): 25–27.
Zhang X, Ma X, Chen X, 2023, The Effect of Xuesaitong Freeze-Dried Powder Injection combined with Betaloc on the Frequency, Duration and Cardiac Function of Angina Pectoris Attacks in Emergency Patients with Coronary Heart Disease and Angina Pectoris. Baotou Medical Journal, 47(3): 19–21.
Jia M, Liang X, Fu G, et al., 2023, Prince Li Xian? Expert Consensus on the Clinical Application of Xuesaitong Soft Capsules. Chinese Journal of Traditional Chinese Medicine, 48 (20): 5668–5674.
Li G, 2021, Evaluation of the Clinical Effect of Xuesaitong Injection in the Treatment of Coronary Heart Disease. Medical Frontiers, 11(9): 41–42.
Chen J, 2021, Effects of Xuesaitong Combined with Dipyridamole on Hemorheological Index Levels and the Frequency of Angina pectoris Attacks in Patients with Coronary Heart Disease. Chinese Journal of Minkang Medicine, 33(6): 94-96.
Cai Y, 2023, The Effect of Xuesaitong as an Adjuvant Therapy on Patients with Coronary Heart Disease and its Influence on Hemorheology. Electronic Journal of Integrated Traditional Chinese and Western Medicine on Cardiovascular Diseases, 11(1): 40–42.
Li H, Wang N, Huang B, 2022, Observation on the Therapeutic Effect of Xuesaitong Soft Capsules in the Treatment of Exertional Angina Pectoris. Chinese Journal of Modern Pharmaceutical Application, 16(20): 6–9.
Liu K, Shen F, 2022, Evaluation of the Intervention Effect of Xuesaitong Soft Capsules in Coronary Atherosclerotic Plaques. Chinese Journal of Modern Drug Application, 16(16): 126–128.
Dong Y, Chen H, Liu Y, et al., 2020, Clinical Study on the Intervention of Xuesaitong Soft Capsules in the lncR CTB114C7.4-miR3656-BCL2A1 Regulatory Network in Patients with Coronary Heart Disease and Blood Stasis Syndrome. World Science and Technology: Modernization of Traditional Chinese Medicine, 22(11): 3846–3852.
Zhang C, Peng Y, Wu H, 2022, The Influence of Xuesaitong on Serum Homocysteine and other Substances in Patients with Angina Pectoris after Interventional Therapy. Northwest Journal of Pharmacy, 37(2): 154–158.
Liang M, 2021, The Efficacy of metoprolol Combined with Xuesaitong Injection in the Treatment of Coronary Heart Disease and Heart Failure and Its Impact on patients’ Blood Rheology and Cardiac Function. Smart Health, 7(27): 169–171.
Share
Back to top
Bio-Byword Scientific Publishing Pty. Ltd.
We are committed to supporting the scientific community by publishing impactful research and fostering effective communication among scientists. We continuously seek ways to accelerate scientific progress while upholding transparency and open dialogue. Our goal is to make knowledge freely and barrier‑free accessible to all.
Contact us: info@bbwpublisher.com
Level 10, 50 Clarence Street Sydney, NSW 2000 Australia